129 related articles for article (PubMed ID: 8116114)
1. Detection of urinary interleukin-2, interleukin-2 receptor, and tumor necrosis factor levels in patients with superficial bladder tumors after intravesical BCG immunotherapy.
Balbay D; Ozen H; Ozkardes H; Barut A; Bakkaloglu M; Tasar C; Remzi D
Urology; 1994 Feb; 43(2):187-90. PubMed ID: 8116114
[TBL] [Abstract][Full Text] [Related]
2. Urinary cytokines during intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer: processing, stability and prognostic value.
de Reijke TM; de Boer EC; Kurth KH; Schamhart DH
J Urol; 1996 Feb; 155(2):477-82. PubMed ID: 8558640
[TBL] [Abstract][Full Text] [Related]
3. Elevations of cytokines interleukin-1, interleukin-2 and tumor necrosis factor in the urine of patients after intravesical bacillus Calmette-Guerin immunotherapy.
Böhle A; Nowc C; Ulmer AJ; Musehold J; Gerdes J; Hofstetter AG; Flad HD
J Urol; 1990 Jul; 144(1):59-64. PubMed ID: 2193171
[TBL] [Abstract][Full Text] [Related]
4. Detection of interleukin 2 in the urine of patients with superficial bladder tumors after treatment with intravesical BCG.
Haaff EO; Catalona WJ; Ratliff TL
J Urol; 1986 Oct; 136(4):970-4. PubMed ID: 3489840
[TBL] [Abstract][Full Text] [Related]
5. Urinary Interleukin-8 and 18 predict the response of superficial bladder cancer to intravesical therapy with bacillus Calmette-Guerin.
Thalmann GN; Sermier A; Rentsch C; Möhrle K; Cecchini MG; Studer UE
J Urol; 2000 Dec; 164(6):2129-33. PubMed ID: 11061941
[TBL] [Abstract][Full Text] [Related]
6. Induction of urinary interleukin-1 (IL-1), IL-2, IL-6, and tumour necrosis factor during intravesical immunotherapy with bacillus Calmette-Guérin in superficial bladder cancer.
De Boer EC; De Jong WH; Steerenberg PA; Aarden LA; Tetteroo E; De Groot ER; Van der Meijden AP; Vegt PD; Debruyne FM; Ruitenberg EJ
Cancer Immunol Immunother; 1992; 34(5):306-12. PubMed ID: 1540977
[TBL] [Abstract][Full Text] [Related]
7. Urinary interleukin-2 monitoring during prolonged bacillus Calmette-Guerin treatment: can it predict the optimal number of instillations?
de Reijke TM; De Boer EC; Kurth KH; Schamhart DH
J Urol; 1999 Jan; 161(1):67-71. PubMed ID: 10037371
[TBL] [Abstract][Full Text] [Related]
8. Serial urinary IL-2, IL-6, IL-8, TNFalpha, UBC, CYFRA 21-1 and NMP22 during follow-up of patients with bladder cancer receiving intravesical BCG.
Sanchez-Carbayo M; Urrutia M; Romani R; Herrero M; Gonzalez de Buitrago JM; Navajo JA
Anticancer Res; 2001; 21(4B):3041-7. PubMed ID: 11712808
[TBL] [Abstract][Full Text] [Related]
9. Urinary interleukin-2 may predict clinical outcome of intravesical bacillus Calmette-Guérin immunotherapy for carcinoma in situ of the bladder.
Watanabe E; Matsuyama H; Matsuda K; Ohmi C; Tei Y; Yoshihiro S; Ohmoto Y; Naito K
Cancer Immunol Immunother; 2003 Aug; 52(8):481-6. PubMed ID: 12707736
[TBL] [Abstract][Full Text] [Related]
10. Role of interleukin-8 in onset of the immune response in intravesical BCG therapy for superficial bladder cancer.
de Boer EC; Somogyi L; de Ruiter GJ; de Reijke TM; Kurth KH; Schamhart DH
Urol Res; 1997; 25(1):31-4. PubMed ID: 9079743
[TBL] [Abstract][Full Text] [Related]
11. Urinary interleukins in patients receiving intravesical Bacillus Calmette-Guerin therapy for superficial bladder cancer.
Fleischmann JD; Toossi Z; Ellner JJ; Wentworth DB; Ratliff TL; Imbembo AL
Cancer; 1989 Oct; 64(7):1447-54. PubMed ID: 2789094
[TBL] [Abstract][Full Text] [Related]
12. Urinary interleukin-8/creatinine level as a predictor of response to intravesical bacillus Calmette-Guerin therapy in bladder tumor patients.
Rabinowitz R; Smith DS; Tiemann DD; Hudson MA
J Urol; 1997 Nov; 158(5):1728-31; discussion 1731-2. PubMed ID: 9334588
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-2 production during intravesical bacille Calmette-Guerin therapy for bladder cancer.
Ratliff TL; Haaff EO; Catalona WJ
Clin Immunol Immunopathol; 1986 Aug; 40(2):375-9. PubMed ID: 3487405
[TBL] [Abstract][Full Text] [Related]
14. Intravesical instillation therapy with bacillus Calmette-Guérin for superficial bladder cancer: study of the mechanism of bacillus Calmette-Guérin immunotherapy.
Shintani Y; Sawada Y; Inagaki T; Kohjimoto Y; Uekado Y; Shinka T
Int J Urol; 2007 Feb; 14(2):140-6. PubMed ID: 17302571
[TBL] [Abstract][Full Text] [Related]
15. Leukocytes and cytokines in the urine of superficial bladder cancer patients after intravesical immunotherapy with bacillus Calmette-Guerin.
De Boer EC; De Jong WH; Steerenberg PA; Van der Meijden AP; Aarden LA; Debruyne FM; Ruitenberg EJ
In Vivo; 1991; 5(6):671-7. PubMed ID: 1810454
[TBL] [Abstract][Full Text] [Related]
16. [Assessment of 8-hydroxy-2'-deoxyguanosine concentrations in bladder cancer patients treated with intravesical BCG instillation].
Kaczmarek P; Błaszczyk J; Fijałkowski P; Sierakowska-Fijałek A; Niemirowicz J; Kasprzak A; Baj Z
Pol Merkur Lekarski; 2005 Oct; 19(112):526-8. PubMed ID: 16379317
[TBL] [Abstract][Full Text] [Related]
17. Detection of urinary TNF, IL 1, and IL 2 after local BCG immunotherapy for bladder carcinoma.
Böhle A; Nowc C; Ulmer AJ; Musehold J; Gerdes J; Hofstetter AG; Flad HD
Cytokine; 1990 May; 2(3):175-81. PubMed ID: 2104221
[TBL] [Abstract][Full Text] [Related]
18. Intravesical bacille Calmette-Guérin induces the antiangiogenic chemokine interferon-inducible protein 10.
Poppas DP; Pavlovich CP; Folkman J; Voest EE; Chen X; Luster AD; O'Donnell MA
Urology; 1998 Aug; 52(2):268-75; discussion 275-6. PubMed ID: 9697793
[TBL] [Abstract][Full Text] [Related]
19. Importance of urinary interleukin-18 in intravesical immunotherapy with bacillus calmette-guérin for superficial bladder tumors.
Eto M; Koga H; Noma H; Yamaguchi A; Yoshikai Y; Naito S
Urol Int; 2005; 75(2):114-8. PubMed ID: 16123563
[TBL] [Abstract][Full Text] [Related]
20. Systemic immune response after intravesical instillation of bacille Calmette-Guérin (BCG) for superficial bladder cancer.
Taniguchi K; Koga S; Nishikido M; Yamashita S; Sakuragi T; Kanetake H; Saito Y
Clin Exp Immunol; 1999 Jan; 115(1):131-5. PubMed ID: 9933432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
